IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $24,643,000 | -40.9% | 1,859,829 | +5.7% | 0.00% | -33.3% |
Q3 2016 | $41,691,000 | -16.4% | 1,759,121 | +1.7% | 0.01% | -25.0% |
Q2 2016 | $49,864,000 | -9.6% | 1,730,188 | +0.5% | 0.01% | -11.1% |
Q1 2016 | $55,133,000 | -23.3% | 1,721,824 | +2.4% | 0.01% | -25.0% |
Q4 2015 | $71,895,000 | +23.8% | 1,681,366 | +2.0% | 0.01% | +20.0% |
Q3 2015 | $58,064,000 | -24.8% | 1,649,071 | -1.9% | 0.01% | -16.7% |
Q2 2015 | $77,212,000 | -8.8% | 1,681,443 | -7.0% | 0.01% | -7.7% |
Q1 2015 | $84,701,000 | +48.1% | 1,807,155 | +0.1% | 0.01% | +44.4% |
Q4 2014 | $57,193,000 | +31.3% | 1,805,324 | -1.7% | 0.01% | +28.6% |
Q3 2014 | $43,543,000 | -23.3% | 1,836,462 | -2.9% | 0.01% | -22.2% |
Q2 2014 | $56,749,000 | +10.1% | 1,892,266 | -3.0% | 0.01% | 0.0% |
Q1 2014 | $51,521,000 | +8.4% | 1,950,085 | +3.2% | 0.01% | +12.5% |
Q4 2013 | $47,515,000 | +2.1% | 1,890,016 | -16.9% | 0.01% | -11.1% |
Q3 2013 | $46,555,000 | +24.9% | 2,274,287 | +21.7% | 0.01% | +12.5% |
Q2 2013 | $37,264,000 | – | 1,868,975 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |